Prof. Mohammad Ghnaimat, Jordan Invited Speaker
Updates on the management of post transplant anemia

Dr. Yoshihiro Itabashi, Japan
Effects and adverse events of hypoxia-inducible factor-prolyl hydroxylase inhibitors administration to kidney transplant recipients at a single center in Japan

Dr. Satish Vaarman Jeyabalan, Singapore
Impact of de novo or worsening of pre-existing valvular heart disease in patients referred to the kidney transplant waitlist – a single centre retrospective cohort study

Dr. Osama Gheith, Egypt
Sodium-Glucose Co-transporter-2 Inhibition Vs. Dipeptidyl peptidase-4 Inhibition in Diabetic Kidney Transplant Recipients: single center experience

Dr. Sana Shadab, India
To study the long-term impact of hepatitis C treatment in terms of viral load and liver fibrosis among the renal allograft recipients

Mr. Fayeq Jeelani Syed, United States
Potential of 250 New Nautical Mile Concentric Circle Allocation System for Improving the Donor/Recipient HLA Matching

Dr. Islam Madadov, Kazakhstan
Impact of CYP3A5 gene polymorphism on tacrolimus pharmacokinetics in kidney transplant patients in Kazakh population

Mr. Liang Wu, Netherlands
Polarized HLA class I expression on renal tubules hinders the detection of donor-specific urinary extracellular vesicles

Dr. Inji Alshaer, United Kingdom
Impact of recipient frailty on infection risk after kidney transplantation